38.26
price down icon5.23%   -2.11
after-market Dopo l'orario di chiusura: 38.26
loading

Qiagen Nv Borsa (QGEN) Ultime notizie

pulisher
04:41 AM

Qiagen Announces Voting Rights Update with Bank of America - TipRanks

04:41 AM
pulisher
04:05 AM

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView

04:05 AM
pulisher
05:38 AM

Redburn cuts QIAGEN stock rating, lowers price target to EUR41 - Investing.com

05:38 AM
pulisher
04:07 AM

Redburn-Atlantic Downgrades QIAGEN NV (QIA:GR) (QGEN) to Neutral - StreetInsider

04:07 AM
pulisher
Apr 03, 2025

Lab Automation Market Top PlayersF. Hoffmann-La Roche, Qiagen - openPR.com

Apr 03, 2025
pulisher
Apr 02, 2025

Personalized Medicine Market Growth Trends 2025-2033: Transition to Customized Medical Care, Developments in Bioinformatics and Genomics, Growing Prevalence of Chronic Diseases - GlobeNewswire Inc.

Apr 02, 2025
pulisher
Apr 01, 2025

QIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts - BioSpace

Apr 01, 2025
pulisher
Apr 01, 2025

Qiagen introduces QIAprep Plasmodium kit to strengthen malaria research efforts - BioSpectrum Asia

Apr 01, 2025
pulisher
Apr 01, 2025

Revolutionary Malaria Test Kit: QIAGEN's New Solution Detects 5 Species with Single-Parasite Sensitivity - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

QIAGEN N.V. Files 2024 Annual Report with SEC - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results - DutchNews.nl

Mar 31, 2025
pulisher
Mar 31, 2025

PTA-CMS: QIAGEN N.V.: Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

QIAGEN Releases Full 2024 Annual Report: Access Complete Financial Data and Analysis - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Are Qiagen N.V.'s (NYSE:QGEN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market? - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

QIAGEN NV : Jefferies reiterates its Buy rating - Marketscreener.com

Mar 28, 2025
pulisher
Mar 28, 2025

Qiagen N.V. (NYSE:QGEN) is a favorite amongst institutional investors who own 81% - simplywall.st

Mar 28, 2025
pulisher
Mar 20, 2025

QIAGEN’s Eco-Friendlier Products Earn Prestigious ACT Label - Business Wire

Mar 20, 2025
pulisher
Mar 18, 2025

Qiagen Manager Pledges Shares in Securities Lending Transaction - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView

Mar 18, 2025
pulisher
Mar 16, 2025

QGEN Stock Might Rise Following Partnership With Genomics England - MSN

Mar 16, 2025
pulisher
Mar 12, 2025

Is it Worth Retaining QIAGEN Stock in Your Portfolio Now? - Yahoo Finance

Mar 12, 2025
pulisher
Mar 11, 2025

Digital Genome Market to Witness Remarkable Growth with QIAGEN, GenomeMe Inc., NanoString Technologies - openPR

Mar 11, 2025
pulisher
Mar 08, 2025

The past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term losses - Yahoo Finance

Mar 08, 2025
pulisher
Mar 07, 2025

Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B - Medical Device Network

Mar 07, 2025
pulisher
Mar 06, 2025

Qiagen at TD Cowen Conference: Strategic Growth Plans Unveiled - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday -March 06, 2025 at 09:14 am EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

QIAGEN Gets US FDA Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel -March 06, 2025 at 04:04 am EST - MarketScreener

Mar 06, 2025
pulisher
Mar 06, 2025

QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio - Silicon Canals

Mar 06, 2025
pulisher
Mar 05, 2025

Market is not liking Qiagen's (NYSE:QGEN) earnings decline as stock retreats 4.7% this week - Simply Wall St

Mar 05, 2025
pulisher
Mar 05, 2025

Analyzing Tevogen Bio (NASDAQ:TVGN) and Qiagen (NYSE:QGEN) - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

QIAGEN Announces Managerial Transactions Involving Performance Stock Units - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

QIAGEN Announces Managerial Stock Transaction - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Qiagen Announces Managerial Stock Unit Grant - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Qiagen Announces Managerial Stock Transactions - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

QIAGEN Announces Managerial Transactions Involving Restricted Stock Units - TipRanks

Mar 04, 2025
pulisher
Mar 03, 2025

Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now - MSN

Mar 03, 2025
pulisher
Mar 03, 2025

Relative Strength Alert For Qiagen - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey

Mar 03, 2025
pulisher
Mar 03, 2025

BioMérieux: complaint lodged by German company Qiagen -March 03, 2025 at 05:57 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing - sharewise

Mar 03, 2025
pulisher
Mar 03, 2025

Qiagen Files Patent Infringement Complaint in Germany Against bioMerieux -March 03, 2025 at 05:02 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

How QIAGEN's Patent Lawsuit Against bioMérieux Could Reshape the TB Testing Market - Stock Titan

Mar 03, 2025
pulisher
Mar 03, 2025

What is Zacks Research’s Estimate for Qiagen Q1 Earnings? - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Qiagen Takes Legal Action To Defend Quantiferon Intellectual Property -March 03, 2025 at 01:04 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 02, 2025

Zacks Research Issues Negative Estimate for Qiagen Earnings - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Zacks Research Forecasts Qiagen's Q4 Earnings (NYSE:QGEN) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Qiagen (NYSE:QGEN) Reaches New 12-Month LowWhat's Next? - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Qiagen (NYSE:QGEN) Receives Average Rating of “Hold” from Brokerages - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Qiagen stock touches 52-week low at $38.48 amid market shifts - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Qiagen stock touches 52-week low at $38.48 amid market shifts By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 25, 2025

Qiagen N.V.: Some Clarity Needed Before Buying The Dip (NYSE:QGEN) - Seeking Alpha

Feb 25, 2025
$133.87
price down icon 3.49%
diagnostics_research DGX
$164.18
price down icon 3.78%
diagnostics_research LH
$225.00
price down icon 3.62%
diagnostics_research WAT
$324.92
price down icon 5.85%
diagnostics_research MTD
$1,022.66
price down icon 6.63%
diagnostics_research IQV
$154.73
price down icon 7.73%
Capitalizzazione:     |  Volume (24 ore):